Stay updated on Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction

Sign up to get notified when there's something new on the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page.
Latest website image capture
Clouds background image

Latest updates to the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The record describes Amgen’s Phase 2 olpasiran study, including its eligibility criteria, treatment arms, outcomes, and study locations. It also provides publications, study documents, and information about individual participant data sharing.
    Difference
    73%
    Check dated 2026-11-07T13:23:14.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.2 to v3.8.0, while the study record remains behind a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-31T13:54:23.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces updates to NIH websites and a terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T18:12:39.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T21:56:58.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T21:52:50.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study details. A Home button is shown, indicating the page is currently inaccessible.
    Difference
    19%
    Check dated 2026-09-19T20:51:00.000Z thumbnail image

Stay in the know with updates to Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction

Enter your email address, and we'll notify you when there's something new on the Olpasiran Study: Clinical Trial for Lipoprotein(a) Reduction page.